Please assess the completion status of the following clinical trial:

Trial Title: Tracking and Exploring the Source of Viral REbound

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* - Age\>18year old~* Nadir CD4\>200/mm3~* CD4/CD8 ratio\> 0.5~* Continuous antiretroviral therapy for more than 2 years~* Plasma Human Immunodeficiency Virus (HIV) 1 Ribonucleic acid (RNA) \<50 copies/ml in the last 2 years~* Viral Load (VL)\<20copies at inclusion~* Patients who are willing to participate and who understand the trial (particularly, the obligation to have protected intercourse during the study).~* Informed consent~* Short half-life treatment~* Health insurance~* A subset of CD4 (T4cells) express CD32a.~Exclusion Criteria:~* - Acquired Immune Deficiency Syndom (AIDS)~* Pregnancy~* Human immunodeficiency virus (HIV)-2 co infection~* Thrombopenia~* Neurological events during primary infection~* Hepatitis B + (HBV+)~* Hepatitis C + (HCV+)~* Cancer during the last 5 years.~* Life expectancy \< 12 months~* Autoimmunity~* Acute infectious disease in the last 60 days.~* Hemoglobin\<7g/dl~* Glomerular filtration \< 60ml/min~* Refusing protected intercourse~* Risk of HIV transmission~* Psychiatric disorders.~* Alcool and drug abuse~* Involvement in another clinical trial evaluating a therapeutic.~* Being under tutorship~* Being deprived of liberty

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Antiretroviral therapy (Type: EXPERIMENTAL): Stopping antiretroviral therapy

Based on this trial design, predict the completion outcome and termination type (if applicable).